![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 219921-94-5
2. Repaglinide Related Compound A
3. (s)-3-methyl-1-(2-piperidinophenyl)butylamine N-acetyl-l-glutamate
4. (s,s')-3-methyl-1-(2-piperidinophenyl)butylamine, N-acetyl-glutamate Salt
5. 1u5q8kd140
6. (s)-3-methyl-1-(2-piperidinophenyl)butylamine N-acetylglutamate Salt
7. (2s)-2-acetamidopentanedioic Acid;(1s)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine
8. (1s)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine N-acetyl-l-glutamate
9. 3-methyl-1-(2-piperidinophenyl)-1-butylamine, (s)-, N-acetyl-l-glutamate
10. (1s)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine; (2s)-2-acetamidopentanedioic Acid
11. (s)-3-methyl-1-(2-piperidinophenyl)butylamine N-acetylglutamate
12. Mfcd09840998
13. Unii-1u5q8kd140
14. Dtxsid50176421
15. Bcp04251
16. Repaglinide Related Compound A [usp]
17. (s)-3-methyl-1-[2-(1-piperidinyl)phenyl]butylamine N-acetyl-l-glutamate Salt
18. Akos015919997
19. Ds-1077
20. (2s)-2-acetamidopentanedioic Acid,(1s)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine
21. Ac-23929
22. Repaglinide Related Compound A Rs [usp]
23. A25000
24. Ec 606-883-4
25. O10220
26. Repaglinide Related Compound A [usp-rs]
27. J-014399
28. Q27252888
29. Repaglinide Related Compound A [usp Impurity]
30. (s)-3-methyl-1-(2-piperidinophenyl)butylaminen-acetyl-l-glutamate
31. 3-methyl-1-(2-piperidinophenyl)butylamine N-acetylglutamate Salt
32. (s,s')-3-methyl-1-(2-piperidinophenyl)butylamine N-acetyl-glutamate Salt
33. (s,s')-3-methyl-1-(2-piperidinophenyl)butylamine,n-acetyl-glutamate Salt
34. N-acetyl-l-glutamate(s)-3-methyl-1-(2-piperidinophenyl)-1-butylamine
35. (2s)-2-acetamidopentanedioic Acid; (1s)-3-methyl-1-[2-(1-piperidyl)phenyl]butan-1-amine
36. (s)-3-methyl-1-(2-piperidine-1-phenyl)butylamine Compound With N-acetyl-l-glutamic Acid
37. L-glutamic Acid, N-acetyl-, Compd. With (.alpha.s)-.alpha.-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine (1:1)
38. L-glutamic Acid, N-acetyl-, Compd. With (alphas)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine (1:1)
Molecular Weight | 435.6 g/mol |
---|---|
Molecular Formula | C23H37N3O5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 9 |
Exact Mass | 435.27332129 g/mol |
Monoisotopic Mass | 435.27332129 g/mol |
Topological Polar Surface Area | 133 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 458 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.